Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit
- 31 July 2005
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 52 (3), 203-208
- https://doi.org/10.1016/j.diagmicrobio.2005.05.002
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Tigecycline: clinical evidence and formulary positioningInternational Journal of Antimicrobial Agents, 2005
- Antimicrobial activity of tigecycline (GAR-936) tested against 3498 recent isolates of Staphylococcusaureus recovered from nosocomial and community-acquired infectionsInternational Journal of Antimicrobial Agents, 2004
- In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infectionsDiagnostic Microbiology and Infectious Disease, 2004
- In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptidesJournal of Antimicrobial Chemotherapy, 2003
- Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against Stenotrophomonas maltophilia.Journal of Antimicrobial Chemotherapy, 2002
- Temporal Changes in Prevalence of Antimicrobial Resistance in 23 U.S. HospitalsEmerging Infectious Diseases, 2002
- In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum β-lactamasesDiagnostic Microbiology and Infectious Disease, 2001
- Frequency of Isolation of Pathogens from Bloodstream, Nosocomial Pneumonia, Skin and Soft Tissue, and Urinary Tract Infections Occurring in European PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2001
- Disk diffusion susceptibility test development for the new glycylcycline, GAR-936Diagnostic Microbiology and Infectious Disease, 1999
- ANTIMICROBIAL RESISTANCE IN INTENSIVE CARE UNITSClinics in Chest Medicine, 1999